IP Library Assignment 037513/0158
Patent Assignment
Reel/Frame 037513/0158

Change of Name

Recorded: 2016-01-13 Pages: 4
Assignor
HIGH POINT PHARMACEUTICS, LLC
Executed: 2015-07-29
Assignee
VTVX HOLDINGS II LLC
4170 MENDENHALL OAKS PARKWAY, HIGH POINT, NORTH CAROLINA, 27265
Covered Property (1)
Tricyclic Compounds as Modulators of Tnf-Alpha Synthesis and as PDE4 Inhibitors
Patent: 9,393,245 →
Application: 14/850,012 →
Publication: US 2015/0374700
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 13, 2016
From: MJALLI, ADNAN M.M.; GADDAM, BAPU; POLISETTI, DHARMA RAO; KOSTURA, MATTHEW J.
To: TRANSTECH PHARMA, INC.
Reel/Frame 037481/0113 →
Assignment of Assignor's Interest Jan 13, 2016
From: TRANSTECH PHARMA, INC.
To: HIGH POINT PHARMACEUTICALS, LLC
Reel/Frame 037481/0143 →
Assignment of Assignor's Interest Jan 13, 2016
From: VTVX HOLDINGS II LLC
To: VTV THERAPEUTICS LLC
Reel/Frame 037481/0159 →
Security Interest Apr 18, 2018
From: VTV THERAPEUTICS LLC
To: HORIZON TECHNOLOGY FINANCE CORPORATION, AS COLLATERAL AGENT
Reel/Frame 045969/0774 →
Release of Security Interest Jan 27, 2021
From: HORIZON TECHNOLOGY FINANCE CORPORATION, AS COLLATERAL AGENT
To: VTV THERAPEUTICS LLC
Reel/Frame 055133/0214 →